However, treatment with BRAF inhibitors paradoxically can enhance FN expression, promoting a more invasive phenotype in BRAF-mutated thyroid cancer cells (Hicks et al. 2023). The gene discussed is BRAF; the disease is thyroid gland carcinoma.